Felvizumab

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Felvizumab ^?
Monoclonal antibody
Type	Whole antibody
Source	Humanized (from mouse)
Target	RSV
Clinical data
Pregnancy cat.	?
Legal status	?
Identifiers
CAS number	167747-20-8^N
ATC code	None
KEGG	D04136^Y
Chemical data
Formula	?
N (what is this?) (verify)

Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.^[1]

[edit] References

^ WHO Drug Information

Monoclonal antibodies for infectious disease and toxins

Fungal ("-fung-")

Human ("-fungu-")	Efungumab

Viral ("-vi(r)-")

Human ("-viru-")	Exbivirumab Foravirumab Libivirumab Rafivirumab Regavirumab Sevirumab Tuvirumab

Humanized ("-vizu-")	Felvizumab Motavizumab Palivizumab Suvizumab

Bacterial ("-ba(c)-")

Human ("-bacu-")	Nebacumab Panobacumab Raxibacumab

Mouse ("-baco-")	Edobacomab

Chimeric ("-baxi-")	Pagibaximab

Humanized ("-bazu-")	Tefibazumab^†

Toxin ("-tox(a)-")

Humanized ("-toxazu-")	Urtoxazumab

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "http://en.wikipedia.org/w/index.php?title=Felvizumab&oldid=466156213"

Hidden categories:

Personal tools

Log in / create account

Interaction

Toolbox

Print/export

Languages

Italiano